NASDAQ:BBH - VanEck Vectors Biotech ETF Stock Price, Forecast & News

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

News coverage about BBH stock has been trending negative recently, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. VanEck Vectors Biotech ETF earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for VanEck Vectors Biotech ETF.

Some companies that are related to VanEck Vectors Biotech ETF include Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF), PIMCO High Income Fund (PHK), General American Investors (GAM), Blackrock Muniyield Insured Fund (MYI), Tekla Healthcare Investors (HQH), Goldman Sachs BDC (GSBD), Solar Capital (SLRC), Invesco Van Kampen Munpl Oprtnty Tr (VMO), Tortoise Energy Infrastructure (TYG), Templeton Global Income Fund (GIM), Invesco Trust for Investment GradeMncpls (VGM) and Blackrock Muniyield Fund (MYD).

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Arlo Technologies (ARLO), International Game Technology (IGT), SPDR S&P 500 ETF Trust (SPY), Alliance MMA (AMMA), Ashford (AINC), Allied Healthcare Products (AHPI), Adobe (ADBE), B&M European Value Retail (BME), Anglo American (AAL) and Deutsche Bank (DBK).

VanEck Vectors Biotech ETF's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include UBS Group AG (1.81%), Murphy Capital Management Inc. (1.43%), Bank of America Corp DE (1.26%), Mogy Joel R Investment Counsel Inc. (0.93%), Jane Street Group LLC (0.79%) and Raymond James & Associates (0.58%).

BBH stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Institute for Wealth Management LLC., Tower Research Capital LLC TRC , Bank of America Corp DE, Boston Research & Management Inc., Murphy Capital Management Inc., Aspiriant LLC and Advisor Group Inc..

BBH stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Raymond James Financial Services Advisors Inc., Ironsides Asset Advisors LLC, Raymond James & Associates, Tufton Capital Management, Bailard Inc., Cypress Capital Group and Howard Wealth Management LLC.

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BBH stock can currently be purchased for approximately $144.75.

VanEck Vectors Biotech ETF has a market capitalization of $369.11 million. View Additional Information About VanEck Vectors Biotech ETF.